Yufeng Li

发表

Combined modality therapy with TRAIL or agonistic death receptor antibodies

P. Oliver, D. Buchsbaum, H. Amm, 2011, Cancer biology & therapy.

The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia

F. Gao, F. Gao, J. Qian, 2010, Leukemia & lymphoma.

Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I

Ruiwen Zhang, Tiepu Liu, Q. Cai, 1998, Cancer Chemotherapy and Pharmacology.

Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth

S. Shrestha, Wei-Zheng Song, B. Kapogiannis, 2009, Human Genetics.

Mechanisms of Drug Sensitization to TRA-8, an Agonistic Death Receptor 5 Antibody, Involve Modulation of the Intrinsic Apoptotic Pathway in Human Breast Cancer Cells

D. Buchsbaum, T. Zhou, A. Steg, 2011, Molecular Cancer Research.

Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes

R. Myers, K. Varley, W. Grizzle, 2016, Cancer Immunology Research.

Identification of three immunologic correlates for HIV type 1 pathogenesis in youth.

Wei-Zheng Song, Craig M. Wilson, Jianming Tang, 2011, AIDS research and human retroviruses.

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

E. Yang, E. Acosta, E. Stringer-Reasor, 2020, Breast cancer research : BCR.

Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.

K. Bland, H. Krontiras, C. Falkson, 2010, Clinical breast cancer.

The Impact of Breast Irradiation and Concurrent Trastuzumab on the Development of Early Cardiac Events: a Dosimetric Analysis

A. Forero, H. Smith, Yufeng Li, 2014 .

Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro

Hui Liu, K. P. Raisch, Yufeng Li, 2010, Anti-cancer drugs.

The role of serum carcinoembryonic antigen in predicting responses to chemotherapy and survival in patients with non-small cell lung cancer.

T. Lv, Yong Song, D. Yuan, 2014, Journal of cancer research and therapeutics.

FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.

N. Chiorazzi, S. Soong, Shouluan Ding, 2008, Blood.

FCRL 2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia

N. Chiorazzi, S. Soong, Shouluan Ding, 2008 .

Human Papillomavirus in Non-Oropharyngeal Head and Neck Cancers: A Systematic Literature Review

M. Brandwein-Gensler, Yufeng Li, T. Isayeva, 2012, Head and Neck Pathology.

Effect of anti-DR5 and chemotherapy on basal-like breast cancer

A. Forero, P. Oliver, D. Buchsbaum, 2012, Breast Cancer Research and Treatment.

Genetic Epidemiology of Glioblastoma Multiforme: Confirmatory and New Findings from Analyses of Human Leukocyte Antigen Alleles and Motifs

M. Butler, R. Kaslow, Liangyuan Hu, 2009, PloS one.

Positive and Negative Associations of Human Leukocyte Antigen Variants with the Onset and Prognosis of Adult Glioblastoma Multiforme

C. Cobbs, R. Kaslow, R. Miike, 2005, Cancer Epidemiology Biomarkers & Prevention.

PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers

E. Yang, W. Grizzle, Shiqin Wei, 2015, Breast Cancer Research and Treatment.

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer

R. Myers, Minetta C. Liu, H. Rugo, 2015, Clinical Cancer Research.

Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity

P. Oliver, D. Buchsbaum, A. Lobuglio, 2012, Breast Cancer Research and Treatment.

Validation of the Risk Model: High-Risk Classification and Tumor Pattern of Invasion Predict Outcome for Patients with Low-Stage Oral Cavity Squamous Cell Carcinoma

E. Rosenthal, M. Urken, A. Negassa, 2013, Head and Neck Pathology.

Prognostic factors in patients with metastatic breast cancer at the time of diagnosis.

Z. Ren, Shiqin Wei, G. Siegal, 2014, Pathology, research and practice.

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

E. Yang, E. Acosta, W. Grizzle, 2023, Breast Cancer Research and Treatment.

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Dafydd G. Thomas, Minetta C. Liu, A. Wolff, 2015, Clinical Cancer Research.

A Pilot Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination with Bevacizumab in Post-Menopausal Women with Newly Diagnosed Estrogen and/or Progesterone Receptor Positive Breast Cancer.

C. Jones, K. Bland, A. Forero, 2009 .

Combined therapy against recurrent and intracranial invasion of sinonasal hemangiopericytoma: A case report.

Wanning Hu, Yufeng Li, Xiaohong Wang, 2015, Oncology letters.

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Brian S. Roberts, R. Myers, Minetta C. Liu, 2020, Breast cancer research : BCR.

Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration

D. Standaert, E. Benveniste, Zhaoqi Yan, 2016, The Journal of Neuroscience.

Prognostic factors in advanced breast cancer: Race and receptor status are significant after development of metastasis.

Z. Ren, Shiqin Wei, T. Shen, 2016, Pathology, research and practice.

Polymorphisms in XPC provide prognostic information in acute myeloid leukemia

J. Qian, Peipei Xu, Baoan Chen, 2012, International Journal of Hematology.

Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs.

G. Siegal, O. Hameed, Shi Wei, 2011, Annals of diagnostic pathology.

Nuclear Grade and Survival in Invasive Lobular Carcinoma: A Case Series with Long‐term Follow‐up

J. Pfeifer, O. Hameed, A. Adams, 2010, The breast journal.

18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition

E. Yang, A. Sorace, Jianbo Wang, 2021, Clinical Cancer Research.

A Comparative Study of Diffuse Large B-Cell Lymphoma (DLBCL) between African Americans and Caucasians: Single-Center Experience at the University of Alabama at Birmingham (UAB).

J. Foran, M. Baird, V. Reddy, 2007 .

SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma

Lizhong Wang, K. Jiao, Dongquan Chen, 2015, International journal of breast cancer.

Less Toxic Chemotherapy in Locally Advanced Breast Cancer

K. Bland, S. Bae, A. Forero, 2020, Southern medical journal.

Expression levels of PARP1 and phospho-p65 protein in human HER2-positive breast cancers.

E. Yang, W. Grizzle, Shiqin Wei, 2015 .

Brian S. Roberts, R. Myers, Minetta C. Liu, 2020, Breast Cancer Research.

Mechanisms of Drug Sensitization to TRA-8, an Agonistic Death Receptor 5 Antibody, Involve Modulation of the Intrinsic Apoptotic Pathway in Human Breast Cancer Cells

D. Buchsbaum, T. Zhou, A. Steg, 2011, Molecular Cancer Research.

FCRL 2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia

N. Chiorazzi, S. Soong, Shouluan Ding, 2008 .

Trial in progress: A phase 1b/2 study of the PARP inhibitor niraparib in combination with trastuzumab in patients with metastatic HER2+ breast cancer (TBCRC 050).

A. Wolff, E. Yang, R. Nanda, 2021, Journal of Clinical Oncology.